Skip to content
10-Q

Quarterly Report

Merck & Co., Inc. MRK

0001628280-24-045689

← back to feed
Filed
Nov 6, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 31, 2024 2.53B sh
Long Term Debt Q3 2024 · Sep 30, 2024 $34.98B
Long Term Debt Q3 2024 · Dec 31, 2023 $33.68B
Short Term Debt Q3 2024 · Sep 30, 2024 $3.15B
Short Term Debt Q3 2024 · Dec 31, 2023 $1.37B
Cash And Equivalents Q3 2024 · Sep 30, 2024 $14.59B
Cash And Equivalents Q3 2024 · Dec 31, 2023 $6.84B
Stockholders Equity Q3 2024 · Sep 30, 2024 $44.5B
Stockholders Equity Q3 2024 · Dec 31, 2023 $37.58B
Current Liabilities Q3 2024 · Sep 30, 2024 $29.59B
Current Liabilities Q3 2024 · Dec 31, 2023 $25.69B
Current Assets Q3 2024 · Sep 30, 2024 $40.36B
Current Assets Q3 2024 · Dec 31, 2023 $32.17B
Total Assets Q3 2024 · Sep 30, 2024 $117.53B
Total Assets Q3 2024 · Dec 31, 2023 $106.68B
Shares Diluted Q3 2024 · Sep 30, 2023 2.55B sh
Shares Diluted Q3 2024 · Sep 30, 2023 2.55B sh
Stock Repurchased Q3 2024 · Sep 30, 2023 $953M
Dividends Paid Q3 2024 · Sep 30, 2023 $5.59B
Capex Q3 2024 · Sep 30, 2023 $2.87B
Operating Cash Flow Q3 2024 · Sep 30, 2023 $12.76B
Eps Diluted Q3 2024 · Sep 30, 2023 $1.86
Eps Diluted Q3 2024 · Sep 30, 2023 $0.62
Eps Basic Q3 2024 · Sep 30, 2023 $1.87
Eps Basic Q3 2024 · Sep 30, 2023 $0.63
Sga Expense Q3 2024 · Sep 30, 2023 $2.52B
Sga Expense Q3 2024 · Sep 30, 2023 $7.7B
Rd Expense Q3 2024 · Sep 30, 2023 $3.31B
Rd Expense Q3 2024 · Sep 30, 2023 $20.9B
Net Income Q3 2024 · Sep 30, 2023 $4.75B
Net Income Q3 2024 · Sep 30, 2023 $1.59B
Cost Of Revenue Q3 2024 · Sep 30, 2023 $4.26B
Cost Of Revenue Q3 2024 · Sep 30, 2023 $12.21B
Revenue Q3 2024 · Sep 30, 2023 $15.96B
Revenue Q3 2024 · Sep 30, 2023 $45.49B